Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP674913.RA8oAQfRFOih2c9u91o-JxiJp_ZmMOpKbxXFS2YW59o34130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP674913.RA8oAQfRFOih2c9u91o-JxiJp_ZmMOpKbxXFS2YW59o34130_assertion type Assertion NP674913.RA8oAQfRFOih2c9u91o-JxiJp_ZmMOpKbxXFS2YW59o34130_head.
- NP674913.RA8oAQfRFOih2c9u91o-JxiJp_ZmMOpKbxXFS2YW59o34130_assertion description "[p53 is usually inactivated by point mutations during tumorigenesis, whereas the expression levels and p63 and p73 are modulated to give tumor cells a selective advantage.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP674913.RA8oAQfRFOih2c9u91o-JxiJp_ZmMOpKbxXFS2YW59o34130_provenance.
- NP674913.RA8oAQfRFOih2c9u91o-JxiJp_ZmMOpKbxXFS2YW59o34130_assertion evidence source_evidence_literature NP674913.RA8oAQfRFOih2c9u91o-JxiJp_ZmMOpKbxXFS2YW59o34130_provenance.
- NP674913.RA8oAQfRFOih2c9u91o-JxiJp_ZmMOpKbxXFS2YW59o34130_assertion SIO_000772 20298673 NP674913.RA8oAQfRFOih2c9u91o-JxiJp_ZmMOpKbxXFS2YW59o34130_provenance.
- NP674913.RA8oAQfRFOih2c9u91o-JxiJp_ZmMOpKbxXFS2YW59o34130_assertion wasDerivedFrom befree-20150227 NP674913.RA8oAQfRFOih2c9u91o-JxiJp_ZmMOpKbxXFS2YW59o34130_provenance.
- NP674913.RA8oAQfRFOih2c9u91o-JxiJp_ZmMOpKbxXFS2YW59o34130_assertion wasGeneratedBy ECO_0000203 NP674913.RA8oAQfRFOih2c9u91o-JxiJp_ZmMOpKbxXFS2YW59o34130_provenance.